Regeneron Pharmaceuticals Inc.
$REGN
Public valuation for Regeneron Pharmaceuticals Inc. (REGN). Fair value, signal, and key metrics — no sign-in required.
Current Price
$623.54
Fairly Valued
Fair Value Estimate
$637
💎
Value
Established company trading at a low multiple
Analyst Consensus
Target: $833.31
34% higher than current
Key Metrics
Market Cap
$65.4B
Forward P/E
14.1x
Operating Margin
17.8%
Revenue Growth
6.7%
PEG Ratio
1.01
Get free watchlist alerts
Join the waitlist for valuation updates on $REGN and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.